BIO-RAD LABORATORIES, INC. (BIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 900M 1.8B 2.7B Q3 '24: 2.6B Q4 '24: 2.6B Q1 '25: 2.5B Q2 '25: 2.6B Q3 '25: 2.6B Q4 '25: 2.6B Q1 '26: 2.6B Q2 '26: 2.6B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 500M 1B 1.5B Q3 '24: 1.4B Q4 '24: 1.4B Q1 '25: 1.4B Q2 '25: 1.3B Q3 '25: 1.3B Q4 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.3B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

0 150M 300M 450M Q4 '23: 337.8M Q1 '24: 320.5M Q2 '24: 332.4M Q3 '24: 305.9M Q4 '24: 268.9M Q1 '25: 248M Q2 '25: 223.6M Q3 '25: 224.4M Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Net Income TTM

-2.4B -1.6B -800M 0 800M 1.6B 2.4B Q3 '24: -778.7M Q4 '24: -1.8B Q1 '25: -2.2B Q2 '25: 319.2M Q3 '25: -675.9M Q4 '25: 759.9M Q1 '26: 168.8M Q2 '26: 222.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 500M 1B 1.5B Q3 '24: 1.2B Q4 '24: 1.2B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

0 200M 400M 600M Q3 '24: 412M Q4 '24: 455.2M Q1 '25: 515.3M Q2 '25: 534.2M Q3 '25: 491.5M Q4 '25: 532.2M Q1 '26: 510.4M Q2 '26: 492.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

0 150M 300M 450M Q3 '24: 247M Q4 '24: 289.6M Q1 '25: 355.5M Q2 '25: 371M Q3 '25: 336.8M Q4 '25: 374.6M Q1 '26: 357.2M Q2 '26: 353.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 10M 20M 30M Q1 '24: 28.5M Q2 '24: 28.4M Q3 '24: 28M Q1 '25: 28M Q2 '25: 27.2M Q3 '25: 26.9M Q1 '26: 27M Q2 '26: 26.8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q3 '24: -27.33 Q4 '24: -65.04 Q1 '25: -76.20 Q2 '25: 11.73 Q3 '25: -24.31 Q4 '25: 27.65 Q1 '26: 5.81 Q2 '26: 7.99 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.